Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
PROCF Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: September 27, 2024
Report Source: 2023 3rd Quarter Report
Sofgen Pharma SA. Stock Analysis PROCF
United States Health Care Micro Cap Report: Sofgen Pharma SA is an international healthcare and pharmaceutical company. The firm develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. The company operates its business through 5 units, which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs, solutions, oral antidiabetic medications, and insulin delivery systems.
Read More Sofgen Pharma SA (PROCF) Chart
Key Statistics of Sofgen Pharma SA (PROCF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.03Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
691.16KAvg. Volume
535.33Dividend Yield
-Financial Metrics & Statements of Sofgen Pharma SA (PROCF)
FAQ's for Sofgen Pharma SA (PROCF)
- According to Musaffa’s Shariah screening methodology, Sofgen Pharma SA (PROCF) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sofgen Pharma SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Sofgen Pharma SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Sofgen Pharma SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Sofgen Pharma SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Sofgen Pharma SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.